The Europe Collagen & Gelatin Market was valued at $315.5 Million in 2025 and projected to reach to $413.6 Million by 2030, representing a compound annual growth rate of 5.6%. Europe's collagen and gelatin market is poised for steady growth through 2030, driven by increasing consumer awareness of health and wellness benefits, particularly in the nutraceutical and cosmetic sectors.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Europe's collagen and gelatin market is valued at USD 315.5 million in 2025, with a projected expansion to USD 413.6 million by 2030, representing a steady CAGR of 5.6%.
Europe maintains a well-established and mature market position, with Germany leading at USD 168.3 million, followed by the UK at USD 92.1 million, reflecting strong regional demand and established supply chains.
Strong demand across pharmaceutical, cosmetic, food, and nutraceutical applications drives market growth, with European consumers showing high preference for quality and certified collagen and gelatin products.
Europe's stringent regulatory framework and quality standards position the region as a premium market, attracting high-value products and supporting sustainable growth in the collagen and gelatin sector.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SURGICAL (Application) |
| Forecast Period | 2025–2039 |
| Growth Rate | CAGR of 5.8% from 2025 to 2039 |
| Largest Segment | COLLAGEN (Product Type) |
| Market Size Base Year (Billions) | ~USD 1.26 (2025) |
| Revenue Forecast (Billions) | ~USD 1.6713 (2039) |
| Segments Covered | Product Type, Source, Application, End User |
4 segment dimensions are covered across the global market.
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| HOSPITALS | 82.8 | 88.3 | 91.7 | 96.3 | 100.8 | 105.8 | 111.1 | 117 | 5 |
| SURGICAL CENTERS | 17.5 | 18.2 | 18.4 | 18.8 | 19.2 | 19.6 | 20.1 | 20.5 | 2.2 |
| TOTAL | 100.3 | 106.5 | 110.1 | 115.1 | 120.1 | 125.4 | 131.2 | 137.6 | 4.6 |
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| HOSPITALS | 44.2 | 49.6 | 51.7 | 54.5 | 57.2 | 60.2 | 63.5 | 67 | 5.3 |
| SURGICAL CENTERS | 8.2 | 8.9 | 9.1 | 9.3 | 9.5 | 9.7 | 10 | 10.3 | 2.5 |
| TOTAL | 52.4 | 58.6 | 60.8 | 63.8 | 66.8 | 69.9 | 73.5 | 77.3 | 4.9 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | United States | Public Company | Neurosurgery,Wound Care,ENT, |
| SMITH+NEPHEW | United Kingdom | Public Company | |
| DSM-FIRMENICH | Switzerland | Public Company | |
| NITTA GELATIN INC. | Japan | Public Company | Collagen Peptides,Gelatin,Medical Gelatin, |
| TESSENDERLO GROUP | Belgium | Public Company | |
| SOLVENTUM | United States | Public Company | Medsurg,Dental Solutions,Health Information Systems, |
| MEDTRONIC PLC | Ireland | Public Company | |
| ZIMVIE INC. | United States | Private Company | Dental Implant Systems,Digital Dentistry Solutions,Restorative Products, |
| COLLAGEN SOLUTIONS PLC | United Kingdom | Private Company | Orthopaedic,Wound Care,3D Cell Culture, |
| BICO | Sweden | Public Company |
Integra LifeSciences Holdings Corporation is a United States-based public company founded in 1989 that employs 4,427 people. The company operates in the medical device and surgical implant sectors.
Smith+Nephew is a United Kingdom-based public company founded in 1856 with 16,988 employees. The company is a global leader in medical technology, specializing in orthopedic reconstruction, advanced wound management, and sports medicine.
DSM-Firmenich is a Switzerland-based public company founded in 1902 with 26,873 employees. The company operates in nutrition, health, and sustainable living sectors, providing innovative solutions for food, beverage, and personal care industries.
Nitta Gelatin Inc. is a Japan-based public company founded in 1918 with 860 employees. The company specializes in gelatin and collagen-based products for pharmaceutical, food, and industrial applications.
Tessenderlo Group is a Belgium-based public company founded in 1919 with 6,945 employees. The company operates across multiple sectors including agriculture, specialty chemicals, and industrial solutions.
Solventum is a United States-based public company founded in 2023 with 20,584 employees. The company operates in healthcare and industrial sectors, providing innovative solutions and products.
Medtronic PLC is an Ireland-based public company founded in 1949 with 95,000 employees. The company is a global leader in medical technology, offering a broad range of products and therapies across cardiac, vascular, and surgical specialties.
Zimvie Inc. is a United States-based private company founded in 2021 with 1,770 employees. The company operates in the medical device sector.
Collagen Solutions PLC is a United Kingdom-based private company founded in 2013 with 48 employees. The company specializes in collagen-based medical and surgical products.
BICO is a Sweden-based public company founded in 2016 with 557 employees. The company specializes in 3D bioprinting and biofabrication technologies for life sciences applications.
| Country | 2025 size (native) |
|---|---|
| Germany | USD 168.3 Million |
| UK | USD 92.1 Million |
| France | USD 56.7 Million |
| Rest Of Europe | USD 137.6 Million |
Europe's collagen and gelatin market is valued at USD 315.5 million in 2025.
Europe's collagen and gelatin market is forecast to reach USD 413.6 million by 2030.
Europe's collagen and gelatin market is expected to grow at a CAGR of 5.6% from 2025 to 2030.
Europe's market is driven by demand across pharmaceuticals, cosmetics, food products, and nutraceutical supplements, particularly for joint health and anti-aging applications.
Europe benefits from an aging population, high disposable incomes, stringent regulatory standards, and strong consumer awareness of health and wellness, positioning it as a mature and innovative market.
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global collagen & gelatin market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to determine the final market size.
The market for the companies offering collagen & gelatin was evaluated by secondary data available through paid and unpaid sources, analyzing the product and service portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives. Secondary data was analyzed to determine the overall size of the global collagen & gelatin market, which was validated through primary research.
Extensive primary research was conducted after acquiring basic knowledge about the global collagen and gelatin market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical and biotechnology companies, and experts from the supply side, such as C-level and D-level executives and managers. These interviews were conducted across major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World (including Latin America, the Middle East, and Africa). The primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.
A breakdown of the primary respondents is given below.
To know about the assumptions considered for the study, download the pdf brochure
The global size of the collagen and gelatin market was estimated and validated through multiple approaches, such as the top-down and bottom-up approaches. These methods were also used extensively to estimate the size of various subsegments in the markets.

After determining the market size from the estimation process explained above, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Collagen is a fibrous structural protein of connective tissue. It is rich in proline and glycine and yields gelatin on hydrolysis. Gelatin is a partially hydrolyzed protein of collagen. Collagen and gelatin are natural biomaterials and are mainly used in wound care and orthopedic applications.
The report covers collagen and gelatin derived from bovine, porcine, and other sources (marine collagen; collagen obtained from chicken, rats, duck, and equine tendons; and recombinant collagen). The report’s scope is restricted to collagen and gelatin end products used for medical applications only. The use of collagen and gelatin as an intermediate product/raw material for pharmaceutical development and manufacturing (to produce hard capsules, softgel capsules, tablet binding or coating, components, or vaccines) and biotechnology applications (such as biomaterials, bioprinting) are not considered in the scope of this report.
Full forecast, segment splits, and company analysis for all Collagen & Gelatin Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report